CEACAM1 and breast cancer: In an effort to identify cis-acting regulatory elements that control the alternative splicing of CEACAM1, we constructed a series of minigenes and examined their splicing by transiently transfecting two breast cancer cell lines, MDA-MB468 and ZR75.